In this bonus episode, GOLD brings you the full feature-length interview with Claire Skentelbery, Director General, EuropaBio. She explores the contribution that biotech will have on Europe’s future and economic footprint, the preparedness of Europe to deliver biotech’s innovative therapies at scale, as well as the investment landscape for biotech-related SMEs.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech

Nurturing homegrown innovation in Europe https://www.emg-gold.com/post/nurturing-home-grown-innovation-in-europe

The hard sell of cell and gene therapies https://www.emg-gold.com/post/the-hard-sell-of-cell-and-gene-therapies